ATE448780T1 - Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung - Google Patents

Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung

Info

Publication number
ATE448780T1
ATE448780T1 AT04788862T AT04788862T ATE448780T1 AT E448780 T1 ATE448780 T1 AT E448780T1 AT 04788862 T AT04788862 T AT 04788862T AT 04788862 T AT04788862 T AT 04788862T AT E448780 T1 ATE448780 T1 AT E448780T1
Authority
AT
Austria
Prior art keywords
modified release
release pharmaceutical
modafinil compositions
compositions
pharmaceutical modafinil
Prior art date
Application number
AT04788862T
Other languages
English (en)
Inventor
Alpa Parikh
Piyush Patel
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34381093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE448780(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon Inc filed Critical Cephalon Inc
Application granted granted Critical
Publication of ATE448780T1 publication Critical patent/ATE448780T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT04788862T 2003-09-18 2004-09-20 Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung ATE448780T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50402803P 2003-09-18 2003-09-18
US10/944,528 US8153159B2 (en) 2003-09-18 2004-09-17 Modafinil modified release pharmaceutical compositions
PCT/US2004/030815 WO2005027890A1 (en) 2003-09-18 2004-09-20 Modafinil modified release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE448780T1 true ATE448780T1 (de) 2009-12-15

Family

ID=34381093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04788862T ATE448780T1 (de) 2003-09-18 2004-09-20 Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung

Country Status (21)

Country Link
US (1) US8153159B2 (de)
EP (1) EP1670447B1 (de)
JP (1) JP5138932B2 (de)
KR (1) KR20060117910A (de)
AR (1) AR046410A1 (de)
AT (1) ATE448780T1 (de)
AU (1) AU2004274017B2 (de)
BR (1) BRPI0414299A (de)
CA (1) CA2536666C (de)
DE (1) DE602004024220D1 (de)
EA (1) EA011400B1 (de)
ES (1) ES2336215T3 (de)
HK (1) HK1089697A1 (de)
IL (1) IL173738A (de)
IS (1) IS2787B (de)
MX (1) MXPA06003125A (de)
MY (1) MY144755A (de)
NO (1) NO20060964L (de)
NZ (1) NZ545573A (de)
TW (1) TWI344840B (de)
WO (1) WO2005027890A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2653839A1 (en) * 1998-11-02 2000-05-11 John G. Devane Multiparticulate modified release composition
JP2008501024A (ja) 2004-05-28 2008-01-17 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 混合コクリスタルおよびそれを含んでなる製薬学的組成物
WO2006063078A2 (en) * 2004-12-08 2006-06-15 Elan Corporation, Plc Topiramate pharmaceuticals composition
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP1986659A4 (de) 2006-02-13 2009-10-21 Vanda Pharmaceuticals Inc Stabile dosierungsformen von formulierungen aus imidazolylalkyl-pyridinen
CA2657409A1 (en) * 2006-07-12 2008-01-17 Elan Corporation, Plc Nanoparticulate formulations of modafinil
DE102006035549A1 (de) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
US20090082461A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched modafinil
JP5250285B2 (ja) * 2008-03-26 2013-07-31 富士フイルム株式会社 経口物用被覆材、可食性容器およびそれらを用いた経口物
WO2010012407A1 (en) * 2008-07-29 2010-02-04 Ashland Licensing And Intellectual Property Llc. Modified additives for suppressing dust formation
RU2012157127A (ru) * 2010-07-06 2014-08-20 Навифарм. Ко., Лтд. Фармацевтическая композиция, содержащая дапоксетин, для перорального введения с замедленным высвобождением
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
CA2947528C (en) 2014-05-01 2023-09-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions
EP3355865A1 (de) 2015-09-29 2018-08-08 Acorda Therapeutics, Inc. Zusammensetzungen aus 4-aminopyridin mit verzögerter freisetzung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6458384B2 (en) 2000-02-23 2002-10-01 Impetus Ag Pharmaceutical with predetermined activity profile
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6489363B2 (en) * 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6344215B1 (en) 2000-10-27 2002-02-05 Eurand America, Inc. Methylphenidate modified release formulations
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
DE60219005T2 (de) 2001-05-25 2007-12-13 Cephalon, Inc. Modafinil umfassende feste pharmazeutische Formulierungen
GB0117618D0 (en) 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil

Also Published As

Publication number Publication date
WO2005027890A1 (en) 2005-03-31
MY144755A (en) 2011-10-31
MXPA06003125A (es) 2006-06-20
NO20060964L (no) 2006-04-18
IS8327A (is) 2006-02-23
EA011400B1 (ru) 2009-02-27
EP1670447B1 (de) 2009-11-18
IL173738A0 (en) 2006-07-05
ES2336215T3 (es) 2010-04-09
TWI344840B (en) 2011-07-11
AR046410A1 (es) 2005-12-07
JP5138932B2 (ja) 2013-02-06
US8153159B2 (en) 2012-04-10
CA2536666C (en) 2012-06-19
EA200600590A1 (ru) 2006-08-25
JP2007518696A (ja) 2007-07-12
DE602004024220D1 (de) 2009-12-31
HK1089697A1 (en) 2006-12-08
CA2536666A1 (en) 2005-03-31
EP1670447A1 (de) 2006-06-21
NZ545573A (en) 2010-02-26
US20050095294A1 (en) 2005-05-05
IS2787B (is) 2012-06-15
AU2004274017A1 (en) 2005-03-31
IL173738A (en) 2012-07-31
AU2004274017B2 (en) 2010-07-08
KR20060117910A (ko) 2006-11-17
TW200520748A (en) 2005-07-01
BRPI0414299A (pt) 2006-11-14

Similar Documents

Publication Publication Date Title
PT1501534E (pt) Formulacoes farmaceuticas
BRPI0511900A (pt) composições farmacêuticas
NO20050132D0 (no) Vaksinesammensetning
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
IS2787B (is) Módafíníllyfjasamsetningar með breytta losun
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
ATE375125T1 (de) Chirurgischer nagel
DK1587478T3 (da) Farmaceutisk sammensætning
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
IS7564A (is) Lyfjablanda með breytta losun
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
IS7582A (is) Hraðlosandi lyfjablanda
NO20044188L (no) Kontrollerte frigjoringsdoseformer
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
DE10291905D2 (de) Pharmazeutische Zusammensetzung
DE602005005033D1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen
NO20034952D0 (no) Farmasöytiske forbindelser
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
ZA200603030B (en) Modafinil modified release pharmaceutical compositions
ATE439841T1 (de) Pharmazeutische zusammensetzungen mit zd6474
NO20044164L (no) Farmasoytiske sammensetninger
DE10107261B4 (de) Pharmazeutische Zusammensetzung
DE112004001429D2 (de) Pharmazeutischer Wirkstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties